Tezepelumab CRSwNP Real World Study (CREW Study)
← catalyst calendarNCT07790198 · readout in 795 d
Sponsored by AstraZeneca (industry) · AZN — their whole pipeline →.
Phase
—
Status
Not yet recruiting
Study type
Observational
Enrollment
100estimated
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-27
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2026-10-01 | estimated | When the study began enrolling |
| Primary completion | 2028-10-31 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2029-09-28 | estimated | The whole study's end, after follow-up |
| First posted | 2026-08-27 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-08-27 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Chronic Rhinosinusitis With Nasal Polyps
Intervention
- Drug: Tezepelumab — also filed as Tezspire
Primary outcome
what the primary-completion date above is the date OFMean change from baseline in sinonasal symptoms measured by SNOT-22 total score
measured at 24 weeks from initiation of tezepelumab treatment.
Related
AZN · their whole pipeline · Chronic Rhinosinusitis readouts · Congress trades in AZN
AZN's other studiesmost recently updated first
- A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors Phase 1/2 · Recruiting
- A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma Phase 2 · Completed
- Study Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an Ileostomy Phase 2 · Active, not recruiting
- UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance — · Recruiting
- The Eplontersen Pregnancy and Lactation Outcomes Study — · Recruiting
Permalink · AZN's whole pipeline · Catalyst calendar · Every registered study · What changed